Silvia Zerbi

Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug

L. Rovati, M. Perrella, A. Bonazzi, 2018, Arthritis Research & Therapy.

Communication and visiting policies in Italian intensive care units during the first COVID-19 pandemic wave and lockdown: a nationwide survey

M. Giacomini, S. Muttini, M. Gemma, 2022, BMC Anesthesiology.